Laurent Poirot, PhD, on the FDA’s IND Clearance for UCART20x22 ByLaurent Poirot, PhDAugust 25th 2022The senior vice president of immunology at Cellectis discussed the company’s investigational dual-targeted CAR-T therapy for B-cell malignancies.